Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 20/20 | 1.00 |
| ▸ | ITGA2B | P08514 | 14/20 | 1.00 |
| ▸ | ITGAV | P06756 | 16/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lotrafiban SCHEMBL29596 | 1.00 | ITGB3 (1.00) | ITGB3ITGA2BITGAV | |
| Lotrafiban SCHEMBL6673128 | 1.00 | ITGB3 (1.00) | ITGB3ITGA2BITGAV | |
| Lotrafiban SCHEMBL919968 | 0.99 | ITGB3 (0.98) | ITGB3ITGA2BITGAV | |
| Lotrafiban SCHEMBL4432242 | 0.98 | ITGB3 (0.96) | ITGB3ITGA2BITGAV | |
| SCHEMBL7499918 | 0.92 | ITGB3 (0.85) | ITGB3ITGA2BITGAV | |
| SCHEMBL8526301 | 0.90 | ITGB3 (0.82) | ITGB3ITGA2BITGAV | |
| SCHEMBL8194605 | 0.90 | ITGB3 (0.82) | ITGB3ITGA2BITGAV | |
| SCHEMBL6675548 | 0.88 | ITGB3 (0.79) | ITGB3ITGA2BITGAV | |
| SCHEMBL6958161 | 0.88 | ITGB3 (0.78) | ITGB3ITGA2BITGAV | |
| SCHEMBL6958164 | 0.88 | ITGB3 (0.78) | ITGB3ITGA2BITGAV |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1995018619-A9 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2004-10-21 | — | — | WO | claimed |
| EP-0738150-B1 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2003-05-02 | — | — | EP | claimed |
| WO-2000063186-A1 | PROCESS AND INTERMEDIATES FOR PREPARING BENZODIAZEPINES | SMITHKLINE BEECHAM PLC (GB) | 2000-10-26 | — | — | WO | claimed |
| US-6117866-A | Bicyclic fibrinogen antagonists | SMITHKLINE BEECHAM CORPORATION (US) | 2000-09-12 | — | — | US | claimed |
| EP-1003514-A1 | CYCLIC AMINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | Merck & Co., Inc. (US) | 2000-05-31 | — | — | EP | claimed |
| WO-1999004794-A1 | CYCLIC AMINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | MERCK & CO., INC. (US) | 1999-02-04 | — | — | WO | claimed |
| EP-0738150-A4 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 1997-03-19 | — | — | EP | claimed |
| EP-0738150-A1 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1996-10-23 | — | — | EP | claimed |
| WO-1995018619-A1 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1995-07-13 | — | — | WO | claimed |
| WO-1995018619-A9 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2004-10-21 | — | — | WO | disclosed |
| EP-0738150-B1 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2003-05-02 | — | — | EP | disclosed |
| WO-2000063186-A1 | PROCESS AND INTERMEDIATES FOR PREPARING BENZODIAZEPINES | SMITHKLINE BEECHAM PLC (GB) | 2000-10-26 | — | — | WO | disclosed |
| US-6117866-A | Bicyclic fibrinogen antagonists | SMITHKLINE BEECHAM CORPORATION (US) | 2000-09-12 | — | — | US | disclosed |
| EP-0738150-A4 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 1997-03-19 | — | — | EP | disclosed |
| EP-0738150-A1 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1996-10-23 | — | — | EP | disclosed |
| WO-1995018619-A1 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1995-07-13 | — | — | WO | disclosed |